Muhammad Zaka Asif, Ph.D | Co-Founder & Managing Partner, Science
Dr. Zaka Asif is a biochemist specializing in the structural elucidation and biological validation of high-value natural products. With a PhD from the Complex Carbohydrate Research Center (CCRC) at the University of Georgia, Zaka bridges the gap between raw chemical discovery and commercialized mechanism. He leads EleganC’s R&D operations, transforming high-complexity analytical workflows into “due-diligence ready” data engines. By leveraging advanced C. elegans modeling and high-resolution NMR/MS, Zaka ensures that every protocol is a strategic move toward clinical and regulatory milestones.
Khizr Iqbal | Co-Founder & Managing Partner, Finance
Khizr Iqbal brings the precision of international asset management and to the frontier of biotechnology. Specializing in institutional financial modeling and strategic capital allocation, Khizr translates complex R&D burn rates into transparent, investor-ready growth strategies. At EleganC, he oversees fiscal governance and partnership structuring, ensuring that scientific discovery is matched by institutional-grade financial discipline. His focus is on optimizing the “Return on Science” (RoS) for global partners and private-sector stakeholders.